sibutramine has been researched along with Arrhythmia in 6 studies
sibutramine: serotonin and norepinephrine transporter inhibitor; Meridia is tradename for sibutramine hydrochloride
Excerpt | Relevance | Reference |
---|---|---|
"This study has shown an elevation in QTd, which may lead to cardiac arrhythmias, after sibutramine treatment." | 7.76 | Elevation of QT dispersion after obesity drug sibutramine. ( Algul, B; Ata, N; Dal, K; Demirel, G; Deveci, OS; Ertugrul, DT; Kucukazman, M; Tutal, E; Yalcin, AA; Yavuz, B; Yilmaz, H, 2010) |
"Addition of low-dose metoprolol to sibutramine therapy increased patient compliance to the treatment, and decreased the frequency and severity of side effects including hypertension and palpitations, without decreasing the drug efficacy or causing significant deleterious changes in metabolic parameters." | 5.11 | Effect of low-dose metoprolol in combination with sibutramine therapy in normotensive obese patients: a randomized controlled study. ( Baykan, M; Durmus, I; Erem, C; Ersoz, HO; Hacihasanoglu, A; Telatar, M; Ukinc, K, 2004) |
"Sibutramine, a serotonin and norepinephrine transporter blocker, is a common adjunctive obesity treatment." | 5.11 | Paradoxical effect of sibutramine on autonomic cardiovascular regulation in obese hypertensive patients--sibutramine and blood pressure. ( Birkenfeld, AL; Jordan, J; Luft, FC; Pischon, T; Schroeder, C; Sharma, AM; Tank, J, 2005) |
"This study has shown an elevation in QTd, which may lead to cardiac arrhythmias, after sibutramine treatment." | 3.76 | Elevation of QT dispersion after obesity drug sibutramine. ( Algul, B; Ata, N; Dal, K; Demirel, G; Deveci, OS; Ertugrul, DT; Kucukazman, M; Tutal, E; Yalcin, AA; Yavuz, B; Yilmaz, H, 2010) |
"Other IMMP case reports suggesting arrhythmias associated with sibutramine were assessed and further reports were obtained from the World Health Organisation (WHO) adverse drug reactions database." | 1.33 | QT interval prolongation associated with sibutramine treatment. ( Clark, DW; Harrison-Woolrych, M; Hill, GR; Rees, MI; Skinner, JR, 2006) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (83.33) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Yalcin, AA | 1 |
Yavuz, B | 1 |
Ertugrul, DT | 1 |
Algul, B | 1 |
Yilmaz, H | 1 |
Deveci, OS | 1 |
Kucukazman, M | 1 |
Ata, N | 1 |
Demirel, G | 1 |
Dal, K | 1 |
Tutal, E | 1 |
Ersoz, HO | 1 |
Ukinc, K | 1 |
Baykan, M | 1 |
Erem, C | 1 |
Durmus, I | 1 |
Hacihasanoglu, A | 1 |
Telatar, M | 1 |
Birkenfeld, AL | 1 |
Schroeder, C | 1 |
Pischon, T | 1 |
Tank, J | 1 |
Luft, FC | 1 |
Sharma, AM | 1 |
Jordan, J | 1 |
Harrison-Woolrych, M | 1 |
Clark, DW | 1 |
Hill, GR | 1 |
Rees, MI | 1 |
Skinner, JR | 1 |
Wooltorton, E | 1 |
Deitel, M | 1 |
2 trials available for sibutramine and Arrhythmia
Article | Year |
---|---|
Effect of low-dose metoprolol in combination with sibutramine therapy in normotensive obese patients: a randomized controlled study.
Topics: Adrenergic beta-Antagonists; Adult; Anthropometry; Appetite Depressants; Arrhythmias, Cardiac; Cyclo | 2004 |
Paradoxical effect of sibutramine on autonomic cardiovascular regulation in obese hypertensive patients--sibutramine and blood pressure.
Topics: Adolescent; Adult; Aged; Appetite Depressants; Arrhythmias, Cardiac; Autonomic Nervous System; Baror | 2005 |
4 other studies available for sibutramine and Arrhythmia
Article | Year |
---|---|
Elevation of QT dispersion after obesity drug sibutramine.
Topics: Adult; Anti-Obesity Agents; Arrhythmias, Cardiac; Caloric Restriction; Combined Modality Therapy; Cy | 2010 |
QT interval prolongation associated with sibutramine treatment.
Topics: Adult; Amino Acid Substitution; Appetite Depressants; Arrhythmias, Cardiac; Cyclobutanes; Electrocar | 2006 |
Obesity drug sibutramine (Meridia): hypertension and cardiac arrhythmias.
Topics: Appetite Depressants; Arrhythmias, Cardiac; Cyclobutanes; Humans; Hypertension; Obesity | 2002 |
Sibutramine warning: hypertension and cardiac arrhythmias reported.
Topics: Appetite Depressants; Arrhythmias, Cardiac; Contraindications; Cyclobutanes; Humans; Hypertension | 2002 |